NeurosciencebioRxivPreprint
Terazosin drives sex-dependent adrenergic-bioenergetic reprogramming to restore network function in Alzheimer's disease
Swastik G Pattanashetty, Peter A. Serrano, Patricia Rockwell…·Maria E. Figueiredo-Pereira
This study identifies terazosin as a drug that reverses AD-related molecular signatures and preserves noradrenergic circuits in a sex-dependent manner in a rat model of Alzheimer's disease.
1 citation